메뉴 건너뛰기




Volumn 61, Issue 2, 2015, Pages 471-480

Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; RIBAVIRIN; SOFOSBUVIR; ANTIVIRUS AGENT; NS-5 PROTEIN, HEPATITIS C VIRUS; URIDINE PHOSPHATE; VIRUS PROTEIN;

EID: 84921503517     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27361     Document Type: Article
Times cited : (71)

References (42)
  • 1
    • 23944506014 scopus 로고    scopus 로고
    • Global epidemiology of hepatitis C virus infection
    • Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-567.
    • (2005) Lancet Infect Dis , vol.5 , pp. 558-567
    • Shepard, C.W.1    Finelli, L.2    Alter, M.J.3
  • 2
    • 84894707183 scopus 로고    scopus 로고
    • Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
    • Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource. Hepatology 2014;59:318-327.
    • (2014) Hepatology , vol.59 , pp. 318-327
    • Smith, D.B.1    Bukh, J.2    Kuiken, C.3    Muerhoff, A.S.4    Rice, C.M.5    Stapleton, J.T.6    Simmonds, P.7
  • 3
    • 7444256169 scopus 로고    scopus 로고
    • Genetic diversity and evolution of hepatitis C virus-15 years on
    • Simmonds P. Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 2004;85:3173-3188.
    • (2004) J Gen Virol , vol.85 , pp. 3173-3188
    • Simmonds, P.1
  • 6
    • 84901624146 scopus 로고    scopus 로고
    • Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus
    • Galli A, Bukh J. Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus. Trends Microbiol 2014;22:354-364.
    • (2014) Trends Microbiol , vol.22 , pp. 354-364
    • Galli, A.1    Bukh, J.2
  • 7
    • 0036196640 scopus 로고    scopus 로고
    • A natural intergenotypic recombinant of hepatitis C virus identified in St
    • Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002;76:4034-4043.
    • (2002) Petersburg. J Virol , vol.76 , pp. 4034-4043
    • Kalinina, O.1    Norder, H.2    Mukomolov, S.3    Magnius, L.O.4
  • 9
    • 54949116213 scopus 로고    scopus 로고
    • Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b
    • Kurbanov F, Tanaka Y, Chub E, Maruyama I, Azlarova A, Kamitsukasa H, et al. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. J Infect Dis 2008;198:1448-1456.
    • (2008) J Infect Dis , vol.198 , pp. 1448-1456
    • Kurbanov, F.1    Tanaka, Y.2    Chub, E.3    Maruyama, I.4    Azlarova, A.5    Kamitsukasa, H.6
  • 16
    • 79953733509 scopus 로고    scopus 로고
    • Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX-950) and danoprevir (ITMN-191)
    • Imhof I, Simmonds P. Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX-950) and danoprevir (ITMN-191). Hepatology 2011;53:1090-1099.
    • (2011) Hepatology , vol.53 , pp. 1090-1099
    • Imhof, I.1    Simmonds, P.2
  • 18
    • 84878976866 scopus 로고    scopus 로고
    • Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naïve patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
    • Kowdley KV, Lawitz E, Crespo I, Hassanein T, Davis MN, DeMicco M, et al. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naïve patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial. Lancet 2013;381:2100-2107.
    • (2013) Lancet , vol.381 , pp. 2100-2107
    • Kowdley, K.V.1    Lawitz, E.2    Crespo, I.3    Hassanein, T.4    Davis, M.N.5    DeMicco, M.6
  • 19
    • 84880964894 scopus 로고    scopus 로고
    • Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naive patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial
    • Rodriguez-Torres M, Lawitz E, Kowdley KV, Nelson DR, Dejesus E, McHutchison JG, et al. Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naive patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial. J Hepatol 2013;58:663-668.
    • (2013) J Hepatol , vol.58 , pp. 663-668
    • Rodriguez-Torres, M.1    Lawitz, E.2    Kowdley, K.V.3    Nelson, D.R.4    Dejesus, E.5    McHutchison, J.G.6
  • 20
    • 84876740954 scopus 로고    scopus 로고
    • Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naïve patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
    • Lawitz E, Lalezari JP, Hassanein T, Kowdley KV, Poordad FF, Sheikh AM, et al. Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naïve patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. Lancet Infect Dis 2013;13:401-408.
    • (2013) Lancet Infect Dis , vol.13 , pp. 401-408
    • Lawitz, E.1    Lalezari, J.P.2    Hassanein, T.3    Kowdley, K.V.4    Poordad, F.F.5    Sheikh, A.M.6
  • 23
  • 26
    • 25844523297 scopus 로고    scopus 로고
    • Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
    • Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-973.
    • (2005) Hepatology , vol.42 , pp. 962-973
    • Simmonds, P.1    Bukh, J.2    Combet, C.3    Deleage, G.4    Enomoto, N.5    Feinstone, S.6
  • 27
    • 34247254413 scopus 로고    scopus 로고
    • Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay
    • Bouchardeau F, Cantaloube JF, Chevaliez S, Portal C, Razer A, Lefrere JJ, et al. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol 2007;45:1140-1145.
    • (2007) J Clin Microbiol , vol.45 , pp. 1140-1145
    • Bouchardeau, F.1    Cantaloube, J.F.2    Chevaliez, S.3    Portal, C.4    Razer, A.5    Lefrere, J.J.6
  • 28
    • 25444523728 scopus 로고    scopus 로고
    • Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications
    • Kurn N, Chen P, Heath JD, Kopf-Sill A, Stephens KM, Wang S. Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications. Clin Chem 2005;51:1973-1981.
    • (2005) Clin Chem , vol.51 , pp. 1973-1981
    • Kurn, N.1    Chen, P.2    Heath, J.D.3    Kopf-Sill, A.4    Stephens, K.M.5    Wang, S.6
  • 30
    • 0032889281 scopus 로고    scopus 로고
    • Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
    • Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-160.
    • (1999) J Virol , vol.73 , pp. 152-160
    • Lole, K.S.1    Bollinger, R.C.2    Paranjape, R.S.3    Gadkari, D.4    Kulkarni, S.S.5    Novak, N.G.6
  • 31
    • 0027968068 scopus 로고
    • CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
    • Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
    • (1994) Nucleic Acids Res , vol.22 , pp. 4673-4680
    • Thompson, J.D.1    Higgins, D.G.2    Gibson, T.J.3
  • 33
    • 33745256005 scopus 로고    scopus 로고
    • Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative
    • Anisimova M, Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst Biol 2006;55:539-552.
    • (2006) Syst Biol , vol.55 , pp. 539-552
    • Anisimova, M.1    Gascuel, O.2
  • 34
    • 77950806408 scopus 로고    scopus 로고
    • New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0
    • Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010;59:307-321.
    • (2010) Syst Biol , vol.59 , pp. 307-321
    • Guindon, S.1    Dufayard, J.F.2    Lefort, V.3    Anisimova, M.4    Hordijk, W.5    Gascuel, O.6
  • 35
    • 77949434590 scopus 로고    scopus 로고
    • Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report
    • Morel V, Descamps V, Francois C, Fournier C, Brochot E, Capron D, et al. Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report. J Clin Virol 2010;47:382-386.
    • (2010) J Clin Virol , vol.47 , pp. 382-386
    • Morel, V.1    Descamps, V.2    Francois, C.3    Fournier, C.4    Brochot, E.5    Capron, D.6
  • 37
    • 84897084133 scopus 로고    scopus 로고
    • Once-daily sofosbuvir plus ribavirin given for 12 or 24 weeks in treatment-naïve patients with HCV infection: the QUANTUM Study
    • Lalezari JP, Nelson DR, Hyland RH, Lin M, Rossi SJ, Symonds WT, et al. Once-daily sofosbuvir plus ribavirin given for 12 or 24 weeks in treatment-naïve patients with HCV infection: the QUANTUM Study. J Hepatol 2013;56(Suppl 1):S88-S100.
    • (2013) J Hepatol , vol.56 , pp. S88-S100
    • Lalezari, J.P.1    Nelson, D.R.2    Hyland, R.H.3    Lin, M.4    Rossi, S.J.5    Symonds, W.T.6
  • 41
    • 84875984443 scopus 로고    scopus 로고
    • Productive homologous and non-homologous recombination of hepatitis C virus in cell culture
    • Scheel TK, Galli A, Li YP, Mikkelsen LS, Gottwein JM, Bukh J. Productive homologous and non-homologous recombination of hepatitis C virus in cell culture. PLoS Pathog 2013;9:e1003228.
    • (2013) PLoS Pathog , vol.9 , pp. e1003228
    • Scheel, T.K.1    Galli, A.2    Li, Y.P.3    Mikkelsen, L.S.4    Gottwein, J.M.5    Bukh, J.6
  • 42
    • 0026602984 scopus 로고
    • RNA recombination in animal and plant viruses
    • Lai MM. RNA recombination in animal and plant viruses. Microbiol Rev 1992;56:61-79.
    • (1992) Microbiol Rev , vol.56 , pp. 61-79
    • Lai, M.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.